Education
About Us
Working with TipRanks
Follow Us
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 70.00K | $ 0.00 | $ 0.00 | $ 1.74M |
| Gross Profit | $ 0.00 | $ 70.00K | $ -12.84K | $ -61.51K | $ 1.74M |
| Operating Income | $ -3.58B | $ -6.65M | $ -9.72M | $ -9.13M | $ -7.58M |
| EBITDA | $ -3.58B | $ -7.16M | $ -5.60M | $ -9.06M | $ -7.61M |
| Net Income | $ -4.52B | $ -7.90M | $ 17.82M | $ -11.39M | $ -11.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 86.13K | $ 170.41K | $ 241.45K | $ 568.77K | $ 474.02K |
| Total Assets | $ 26.68M | $ 30.01M | $ 36.12M | $ 23.61M | $ 23.66M |
| Total Debt | $ 13.09M | $ 12.57M | $ 11.26M | $ 8.99M | $ 5.43M |
| Net Debt | $ 13.00M | $ 12.40M | $ 11.02M | $ 8.42M | $ 4.96M |
| Total Liabilities | $ 19.20M | $ 18.40M | $ 16.92M | $ 15.45M | $ 11.18M |
| Stockholders' Equity | $ 8.25M | $ 12.13M | $ 19.41M | $ 7.96M | $ 11.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -740.27K | $ -1.32M | $ -1.45M | $ -4.43M | $ -2.81M |
| Operating Cash Flow | $ -740.27K | $ -1.32M | $ -1.45M | $ -4.43M | $ -2.81M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 656.00K | $ 1.25M | $ 1.13M | $ 4.53M | $ 3.22M |